| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9B583
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.538 |
| CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.535 |
| CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.638 |
| CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.725 |
| CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.667 |
| CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.643 |
| CLV_PCSK_KEX2_1 | 265 | 267 | PF00082 | 0.533 |
| CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.553 |
| CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.652 |
| CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.725 |
| CLV_PCSK_PC1ET2_1 | 120 | 122 | PF00082 | 0.690 |
| CLV_PCSK_PC1ET2_1 | 151 | 153 | PF00082 | 0.668 |
| CLV_PCSK_PC1ET2_1 | 265 | 267 | PF00082 | 0.533 |
| CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.443 |
| CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.565 |
| CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.666 |
| DOC_PP4_FxxP_1 | 65 | 68 | PF00568 | 0.674 |
| DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.627 |
| DOC_USP7_MATH_1 | 226 | 230 | PF00917 | 0.616 |
| DOC_WW_Pin1_4 | 284 | 289 | PF00397 | 0.743 |
| LIG_14-3-3_CanoR_1 | 114 | 124 | PF00244 | 0.624 |
| LIG_14-3-3_CanoR_1 | 215 | 221 | PF00244 | 0.351 |
| LIG_14-3-3_CanoR_1 | 280 | 285 | PF00244 | 0.728 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.664 |
| LIG_BRCT_BRCA1_1 | 275 | 279 | PF00533 | 0.579 |
| LIG_BRCT_BRCA1_1 | 280 | 284 | PF00533 | 0.691 |
| LIG_FHA_1 | 192 | 198 | PF00498 | 0.676 |
| LIG_FHA_1 | 27 | 33 | PF00498 | 0.626 |
| LIG_FHA_1 | 92 | 98 | PF00498 | 0.601 |
| LIG_FHA_2 | 160 | 166 | PF00498 | 0.661 |
| LIG_FHA_2 | 215 | 221 | PF00498 | 0.466 |
| LIG_FHA_2 | 56 | 62 | PF00498 | 0.710 |
| LIG_IBAR_NPY_1 | 273 | 275 | PF08397 | 0.561 |
| LIG_LIR_Apic_2 | 198 | 204 | PF02991 | 0.560 |
| LIG_LIR_Gen_1 | 94 | 104 | PF02991 | 0.634 |
| LIG_LIR_Nem_3 | 101 | 107 | PF02991 | 0.517 |
| LIG_LIR_Nem_3 | 20 | 26 | PF02991 | 0.510 |
| LIG_LIR_Nem_3 | 249 | 254 | PF02991 | 0.489 |
| LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.643 |
| LIG_Pex14_2 | 104 | 108 | PF04695 | 0.393 |
| LIG_SH2_CRK | 205 | 209 | PF00017 | 0.566 |
| LIG_SH2_CRK | 275 | 279 | PF00017 | 0.612 |
| LIG_SH2_NCK_1 | 275 | 279 | PF00017 | 0.612 |
| LIG_SH2_PTP2 | 201 | 204 | PF00017 | 0.565 |
| LIG_SH2_STAP1 | 275 | 279 | PF00017 | 0.579 |
| LIG_SH2_STAT3 | 234 | 237 | PF00017 | 0.652 |
| LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.587 |
| LIG_SH3_1 | 21 | 27 | PF00018 | 0.544 |
| LIG_SH3_3 | 21 | 27 | PF00018 | 0.583 |
| LIG_SH3_3 | 285 | 291 | PF00018 | 0.553 |
| LIG_SUMO_SIM_par_1 | 255 | 260 | PF11976 | 0.582 |
| LIG_TYR_ITSM | 73 | 80 | PF00017 | 0.709 |
| LIG_UBA3_1 | 263 | 271 | PF00899 | 0.549 |
| LIG_WW_3 | 287 | 291 | PF00397 | 0.676 |
| MOD_CDK_SPxK_1 | 284 | 290 | PF00069 | 0.673 |
| MOD_CK1_1 | 2 | 8 | PF00069 | 0.684 |
| MOD_CK1_1 | 214 | 220 | PF00069 | 0.510 |
| MOD_CK1_1 | 229 | 235 | PF00069 | 0.552 |
| MOD_CK2_1 | 159 | 165 | PF00069 | 0.665 |
| MOD_CK2_1 | 214 | 220 | PF00069 | 0.599 |
| MOD_CK2_1 | 55 | 61 | PF00069 | 0.713 |
| MOD_Cter_Amidation | 49 | 52 | PF01082 | 0.699 |
| MOD_Cter_Amidation | 7 | 10 | PF01082 | 0.668 |
| MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.699 |
| MOD_GSK3_1 | 116 | 123 | PF00069 | 0.650 |
| MOD_GSK3_1 | 134 | 141 | PF00069 | 0.645 |
| MOD_GSK3_1 | 191 | 198 | PF00069 | 0.685 |
| MOD_GSK3_1 | 210 | 217 | PF00069 | 0.316 |
| MOD_GSK3_1 | 229 | 236 | PF00069 | 0.572 |
| MOD_GSK3_1 | 26 | 33 | PF00069 | 0.591 |
| MOD_GSK3_1 | 274 | 281 | PF00069 | 0.580 |
| MOD_GSK3_1 | 87 | 94 | PF00069 | 0.573 |
| MOD_N-GLC_1 | 189 | 194 | PF02516 | 0.587 |
| MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.573 |
| MOD_N-GLC_1 | 70 | 75 | PF02516 | 0.651 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.673 |
| MOD_NEK2_1 | 138 | 143 | PF00069 | 0.591 |
| MOD_NEK2_1 | 181 | 186 | PF00069 | 0.554 |
| MOD_NEK2_1 | 189 | 194 | PF00069 | 0.596 |
| MOD_NEK2_1 | 211 | 216 | PF00069 | 0.574 |
| MOD_NEK2_1 | 233 | 238 | PF00069 | 0.534 |
| MOD_NEK2_1 | 243 | 248 | PF00069 | 0.446 |
| MOD_NEK2_1 | 70 | 75 | PF00069 | 0.696 |
| MOD_NEK2_1 | 99 | 104 | PF00069 | 0.653 |
| MOD_NEK2_2 | 274 | 279 | PF00069 | 0.583 |
| MOD_PIKK_1 | 214 | 220 | PF00454 | 0.473 |
| MOD_PIKK_1 | 233 | 239 | PF00454 | 0.606 |
| MOD_PKA_1 | 120 | 126 | PF00069 | 0.621 |
| MOD_PKA_2 | 120 | 126 | PF00069 | 0.652 |
| MOD_PKA_2 | 195 | 201 | PF00069 | 0.704 |
| MOD_PKA_2 | 214 | 220 | PF00069 | 0.314 |
| MOD_Plk_1 | 189 | 195 | PF00069 | 0.665 |
| MOD_Plk_4 | 134 | 140 | PF00069 | 0.585 |
| MOD_Plk_4 | 226 | 232 | PF00069 | 0.641 |
| MOD_Plk_4 | 274 | 280 | PF00069 | 0.589 |
| MOD_Plk_4 | 99 | 105 | PF00069 | 0.641 |
| MOD_ProDKin_1 | 284 | 290 | PF00069 | 0.745 |
| MOD_SUMO_rev_2 | 268 | 272 | PF00179 | 0.528 |
| TRG_DiLeu_BaEn_2 | 37 | 43 | PF01217 | 0.678 |
| TRG_ENDOCYTIC_2 | 205 | 208 | PF00928 | 0.608 |
| TRG_ENDOCYTIC_2 | 275 | 278 | PF00928 | 0.604 |
| TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.639 |
| TRG_ER_diArg_1 | 34 | 37 | PF00400 | 0.541 |
| TRG_ER_diArg_1 | 9 | 11 | PF00400 | 0.713 |
| TRG_Pf-PMV_PEXEL_1 | 41 | 46 | PF00026 | 0.696 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PAU8 | Leptomonas seymouri | 60% | 100% |
| A0A1X0PA38 | Trypanosomatidae | 29% | 100% |
| A0A3Q8ILA3 | Leishmania donovani | 91% | 96% |
| A0A3R7KSA4 | Trypanosoma rangeli | 31% | 100% |
| A4HB13 | Leishmania braziliensis | 75% | 100% |
| A4IA70 | Leishmania infantum | 91% | 100% |
| C9ZM36 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
| Q4Q2Q0 | Leishmania major | 91% | 100% |
| V5BV16 | Trypanosoma cruzi | 32% | 100% |